Charles W. Newton
CIK 1866219 · Chief Financial Officer · last filed 2026-06-09
Charles W. Newton is a Chief Financial Officer who has filed 19 SEC Form 4 insider transactions across 5 companies since 2022. The most recent filing, for CHRS, was dated Jun 9, 2026. Across all open-market trades the lifetime net is +$93.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $602.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$602.3K
5
19
$93.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CHRS | Director | 30,000 | $1.40 | $42.0K | $0 | 5 | 2026-06-09 |
| NVAX | Director | 9,520 | $8.88 | $84.5K | $0 | 2 | 2026-04-28 |
| KROS | Director | 13,215 | $10.15 | $134.1K | $0 | 1 | 2026-03-11 |
| LYEL | Chief Financial Officer | 25,306 | $13.50 | $341.6K | $93.5K | 8 | 2025-08-22 |
| 2seventy bio, Inc. (TSVT) Delisted | Director | 22,625 | $5.00 | $113.1K | $0 | 2 | 2024-06-12 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-09 | CHRS | Grant (A) | +30,000 | $0 | EDGAR |
| 2026-04-28 | NVAX | Exer (M) | +9,520 | $0 | EDGAR |
| 2026-03-11 | KROS | Grant (A) | +13,215 | $0 | EDGAR |
| 2025-08-22 | LYEL | Mixed | +6,547 | -$15.3K | EDGAR |
| 2025-08-13 | LYEL | Sell (S) | −267 | -$2.8K | EDGAR |
| 2025-06-13 | CHRS | Grant (A) | — | $0 | EDGAR |
| 2025-05-15 | — | Mixed | −22,625 | $0 | |
| 2025-04-29 | NVAX | Grant (A) | — | $0 | EDGAR |
| 2025-03-18 | LYEL | Buy (P) | +200,000 | $111.6K | EDGAR |
| 2025-02-26 | LYEL | Grant (A) | +112,500 | $0 | EDGAR |